Varadarajan Parthasarathy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Varadarajan Parthasarathy has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
R. Manavalan
Annamalai University
3 shared publicationsV. Senthil Kumar
Immunology Laboratory, Department of Pharmacy, Annamalai University, Annamalai Nagar-608002, Tamil Nadu, India
3 shared publicationsAdrian Higginbottom
School of Medicine and Biomedical Sciences, University of Sheffield Medical School, Sheffield, UK
2 shared publicationsFrancine Martin
School of Medicine and Biomedical Sciences, University of Sheffield Medical School, Sheffield, UK
2 shared publications- Gregory William Moseley
Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia
2 shared publications - Murugesan Arumugam
Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu 600116, India; RXTECH Pharma Private Ltd, Dulip Aprt, Nehru Nagar, Thiruvengadnagar, Tiruvallur, Ambattur, Tamil Nadu 600053, India
2 shared publications
Latest Publications
- Open Access
- 7 September 2023
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 84-92
IN SILICO MOLECULAR SCREENING AND DOCKING APPROACHES ON ANTINEOPLASTIC AGENT-IRINOTECAN TOWARDS THE MARKER PROTEINS OF COLON CANCER
Objective: The present investigation explores the binding affinities of Irinotecan, which is a topoisomerase I inhibitor, against the targets such as AKT1, TNKS-2, MMP, EGFR, TNKS-1, and BRAF, which are the protein that was overexpressed by colorectal carcinogenesis. Methods: In this study, the drug structure was drawn by chemdraw software and explored for its anti-cancer potential by Schrodinger software against selected targeted proteins such as epidermal growth factor receptor (EGFR), matrix metalloproteinase (MMPs), serine/threonine protein kinase Ba (AKT1), BRAF, tankyrases 1 (TNKS-1, and tankyrases 2 (TNKS-2). Results: From the results of docking analysis, the targets with the maximum binding affinity towards the preselected drug Irinotecan were further subjected to ADME prediction by the QikProp module of Schrodinger Maestro version 2018.4. Molecular docking analysis revealed that surface protein targets AKT1, TNKS-2, MMP, and EGFR have the highest binding affinity towards the selected topoisomerase I inhibitor Irinotecan when compared to TNKS-1 and BRAF targets. The higher docking score of Irinotecan with extracellular colorectal cancer target proteins was discovered in this investigation. Conclusion: Cancer is one of the most prevalent, lethal and risky malignant pathologies with an elevated prevalence and mortality rate worldwide. The current work will be more beneficial for rationalising the effective anticancer treatment according to the intensities of expression of the colon cancer target protein and for creating an optimum targeted drug delivery system of an anticancer agent to treat colon cancer.
- 7 September 2023
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 84-92
Open AccessIN SILICO MOLECULAR SCREENING AND DOCKING APPROACHES ON ANTINEOPLASTIC AGENT-IRINOTECAN TOWARDS THE MARKER PROTEINS OF COLON CANCER
Objective: The present investigation explores the binding affinities of Irinotecan, which is a topoisomerase I inhibitor, against the targets such as AKT1, TNKS-2, MMP, EGFR, TNKS-1, and BRAF, which are the protein that was overexpressed by colorectal carcinogenesis. Methods: In this study, the drug structure was drawn by chemdraw software and explored for its anti-cancer potential by Schrodinger software against selected targeted proteins such as epidermal growth factor receptor (EGFR), matrix metalloproteinase (MMPs), serine/threonine protein kinase Ba (AKT1), BRAF, tankyrases 1 (TNKS-1, and tankyrases 2 (TNKS-2). Results: From the results of docking analysis, the targets with the maximum binding affinity towards the preselected drug Irinotecan were further subjected to ADME prediction by the QikProp module of Schrodinger Maestro version 2018.4. Molecular docking analysis revealed that surface protein targets AKT1, TNKS-2, MMP, and EGFR have the highest binding affinity towards the selected topoisomerase I inhibitor Irinotecan when compared to TNKS-1 and BRAF targets. The higher docking score of Irinotecan with extracellular colorectal cancer target proteins was discovered in this investigation. Conclusion: Cancer is one of the most prevalent, lethal and risky malignant pathologies with an elevated prevalence and mortality rate worldwide. The current work will be more beneficial for rationalising the effective anticancer treatment according to the intensities of expression of the colon cancer target protein and for creating an optimum targeted drug delivery system of an anticancer agent to treat colon cancer.
- 10 July 2023
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 23 (12) , 1376-1387
LCMS Determination and Cytotoxicity of Abrus precatorius on L6 and SK-N-MC Cell Lines
Objective: The present study aimed to investigate the cytotoxic effect of various extracts derived from Abrus precatorius Linn. leaves on rat L6 and human SK-N-MC neuroblastoma cell lines and determine the secondary metabolites responsible for the cytotoxicity of Abrus precatorius. Methods: Successive solvent extraction of A. precatorius leaves was carried out using the Soxhlet apparatus with solvents such as petroleum ether, chloroform, ethyl acetate, and ethanol. HPTLC fingerprinting and LC-MS studies were performed to assess the presence of secondary metabolites, such as flavonoids and phenols, in the ethyl acetate extract. Furthermore, the cytotoxic effect of extracts was tested on rat skeletal muscle cell line L6 and human neuroblastoma cell line SK-N-MC using MTT assay. Results: The total phenolic content of ethyl acetate and ethanol extracts of A. precatorius were 72.67 and 60.73 mg, respectively, of GAE/g dry weight of the extract. The total flavonoid content of ethyl acetate and ethanol extract of A. precatorius were 107.33 and 40.66 mg of Quercetin equivalents/g dry weight of the extract. LCMS analysis demonstrated that the flavonoids in specific Naringenin, Diosmetin, Glycitin, and Genistein might play a prominent role in the cytotoxicity of A. precatorius. The cytotoxicity study revealed that the extracts of A. precatorius were non-toxic to rat L6 myotubes, and the IC50 values of the various extracts, such as APPE, APCH, APEA, and APET, were >100 μg/ml. The extracts exhibited cytotoxic activity against human neuroblastoma SK-N-MC cells, and the IC50 values of APPE, APCH, APEA, APET, and the standard drug “Cisplatin” were >100, >100, 64.88, >100, and 3.72 μg/ml, respectively. Conclusion: It was concluded from the study that the extracts of Abrus precatorius were cytotoxic to neuroblastoma cell lines but non-toxic to normal cell lines. HPTLC and LC-MS studies confirmed that flavonoids in the ethyl acetate extract could be responsible for the biological activity.
- 10 July 2023
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 23 (12) , 1376-1387
LCMS Determination and Cytotoxicity of Abrus precatorius on L6 and SK-N-MC Cell Lines
Objective: The present study aimed to investigate the cytotoxic effect of various extracts derived from Abrus precatorius Linn. leaves on rat L6 and human SK-N-MC neuroblastoma cell lines and determine the secondary metabolites responsible for the cytotoxicity of Abrus precatorius. Methods: Successive solvent extraction of A. precatorius leaves was carried out using the Soxhlet apparatus with solvents such as petroleum ether, chloroform, ethyl acetate, and ethanol. HPTLC fingerprinting and LC-MS studies were performed to assess the presence of secondary metabolites, such as flavonoids and phenols, in the ethyl acetate extract. Furthermore, the cytotoxic effect of extracts was tested on rat skeletal muscle cell line L6 and human neuroblastoma cell line SK-N-MC using MTT assay. Results: The total phenolic content of ethyl acetate and ethanol extracts of A. precatorius were 72.67 and 60.73 mg, respectively, of GAE/g dry weight of the extract. The total flavonoid content of ethyl acetate and ethanol extract of A. precatorius were 107.33 and 40.66 mg of Quercetin equivalents/g dry weight of the extract. LCMS analysis demonstrated that the flavonoids in specific Naringenin, Diosmetin, Glycitin, and Genistein might play a prominent role in the cytotoxicity of A. precatorius. The cytotoxicity study revealed that the extracts of A. precatorius were non-toxic to rat L6 myotubes, and the IC50 values of the various extracts, such as APPE, APCH, APEA, and APET, were >100 μg/ml. The extracts exhibited cytotoxic activity against human neuroblastoma SK-N-MC cells, and the IC50 values of APPE, APCH, APEA, APET, and the standard drug “Cisplatin” were >100, >100, 64.88, >100, and 3.72 μg/ml, respectively. Conclusion: It was concluded from the study that the extracts of Abrus precatorius were cytotoxic to neuroblastoma cell lines but non-toxic to normal cell lines. HPTLC and LC-MS studies confirmed that flavonoids in the ethyl acetate extract could be responsible for the biological activity.
- Open Access
- 14 December 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (56B) , 195-206
Cytotoxic Effect of Ethanol Extract of Abrus precatorius Leaves on Raw 264.7 and SK-N-SH Cell lines
Aim: This study was aimed to investigate the cytotoxic effect of ethanol extract of Abrus precatorius. leaves on Raw 264.7 and SK-N-SH cell lines. Methodology: Soxhlet extraction was carried out using absolute alcohol and subsequently, the profiling of phytoconstituents of ethanol extract was performed by LC-MS analysis. Results: The results showed that the presence of anthocyanin, phenolic acid, carboxylic acid, amino acid and monoester in ethanol extract of Abrus precatorius. The phytoconstituents such as picolinic acid, N-Acetyl-DL-tryptophan, 3-Hydroxybenzoic acid, kuromanin, aflatoxin G2, monobutyl Phthalate, laurolactam, 4-Dodecylbenzenesulfonic acid, 4-Methoxycinnamic acid, caffeic acid and octyl decyl phthalate were found in ethanol extract. In addition to this, the cytotoxic effect of the ethanol extract was tested on Raw 264.7 and SK-N-SH cell lines using MTT assay. The cytotoxic study revealed that the ethanol extract of Abrus precatorius was non-toxic to Raw 264.7 cell, but it showed a toxic effect on human neuroblastoma cell line, SK-N-SH. Conclusion: In this study, it was observed that the ethanol extract of Abrus precatorius was non-toxic to Raw 264.7 cell line, but it exhibited strong inhibition on the viability of SK-N-SH cell line.
- 14 December 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (56B) , 195-206
Open AccessCytotoxic Effect of Ethanol Extract of Abrus precatorius Leaves on Raw 264.7 and SK-N-SH Cell lines
Aim: This study was aimed to investigate the cytotoxic effect of ethanol extract of Abrus precatorius. leaves on Raw 264.7 and SK-N-SH cell lines. Methodology: Soxhlet extraction was carried out using absolute alcohol and subsequently, the profiling of phytoconstituents of ethanol extract was performed by LC-MS analysis. Results: The results showed that the presence of anthocyanin, phenolic acid, carboxylic acid, amino acid and monoester in ethanol extract of Abrus precatorius. The phytoconstituents such as picolinic acid, N-Acetyl-DL-tryptophan, 3-Hydroxybenzoic acid, kuromanin, aflatoxin G2, monobutyl Phthalate, laurolactam, 4-Dodecylbenzenesulfonic acid, 4-Methoxycinnamic acid, caffeic acid and octyl decyl phthalate were found in ethanol extract. In addition to this, the cytotoxic effect of the ethanol extract was tested on Raw 264.7 and SK-N-SH cell lines using MTT assay. The cytotoxic study revealed that the ethanol extract of Abrus precatorius was non-toxic to Raw 264.7 cell, but it showed a toxic effect on human neuroblastoma cell line, SK-N-SH. Conclusion: In this study, it was observed that the ethanol extract of Abrus precatorius was non-toxic to Raw 264.7 cell line, but it exhibited strong inhibition on the viability of SK-N-SH cell line.
- 9 December 2021
- Published by Sciencedomain International in Current Journal of Applied Science and Technology
- p. 29-38
In silico Molecular Docking Analysis of Imatinib to Target the Marker Proteins of Breast Cancer
Cancer is an uncontrolled over growth of abnormal cells elsewhere in the body. It is the second leading cause of death globally due to non communicable disease. Among the various types of cancers, the incidence of breast cancer is next to lung cancer. The most commonly used drugs to treat breast cancer are namely, Anastrozole, Arimidex, Letrozol, Imatinib, Tamoxifen, Raloxifene, Toremifene and so on. The hope is to establish the specificity of the drug Imatinib towards the selective potential breast cancers such as mammalian target of rapamycin, (mTOR), human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), poly (ADP-Ribose) polymerase (PARP) and phosphoprotein 53 (p53). To identify the promising target, the Schrodinger software was utilized for the study. The study helped to evaluate the pharmacokinetic properties and binding efficiency of Imatinib towards the breast cancer proteins. The results of study showed that the Imatinib exhibited better binding affinities to mTOR and HER2 as compared to ER, PARP and P53 proteins. The present study will be more useful to rationalize the anticancer therapy based on the expression levels of the target protein in the cancer microenvironment.
- 9 December 2021
- Published by Sciencedomain International in Current Journal of Applied Science and Technology
- p. 29-38
In silico Molecular Docking Analysis of Imatinib to Target the Marker Proteins of Breast Cancer
Cancer is an uncontrolled over growth of abnormal cells elsewhere in the body. It is the second leading cause of death globally due to non communicable disease. Among the various types of cancers, the incidence of breast cancer is next to lung cancer. The most commonly used drugs to treat breast cancer are namely, Anastrozole, Arimidex, Letrozol, Imatinib, Tamoxifen, Raloxifene, Toremifene and so on. The hope is to establish the specificity of the drug Imatinib towards the selective potential breast cancers such as mammalian target of rapamycin, (mTOR), human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), poly (ADP-Ribose) polymerase (PARP) and phosphoprotein 53 (p53). To identify the promising target, the Schrodinger software was utilized for the study. The study helped to evaluate the pharmacokinetic properties and binding efficiency of Imatinib towards the breast cancer proteins. The results of study showed that the Imatinib exhibited better binding affinities to mTOR and HER2 as compared to ER, PARP and P53 proteins. The present study will be more useful to rationalize the anticancer therapy based on the expression levels of the target protein in the cancer microenvironment.
- 1 December 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (52B) , 144-150
Assessing the Molecular Interaction between Poly Lactic-co-glycolic Acid (PLGA) 50:50 and Poly Ethylene Glycol in Presence of Diethyl Phthalate Using in silico Study - A Novel Approach of Pre-Formulation Study
The efficacy of a drug relies on drug formulation and targeting. Imatinib is an anti-cancer drug identified to be effective in the treatment of cancers like myeloid leukemia and lymphoblastic leukemia, and gastrointestinal tumors. The prediction of mixing energy and identification of docking interactions and scores can help identify the most efficient drug carrier/plasticizer molecule that could exert maximum pharmaceutical efficiency. The results of a preliminary study explicitly showed the potent carrier molecule before conducting formulation studies. Hence, the present study was designed to screen the interaction energies between different combinations of Poly (lactic-co-glycolic acid) (PGLA) or Poly Ethylene Glycol (PEG) or diethyl phthalate with Imatinib using in silico computational methods. The study results suggested that the binding energy and the score obtained for docking interactions for Imatinib versus diethyl phthalate was better when compared to the other combinations. Therefore, Diethyl phthalate might be a signature candidate to act as Imatinib-carrier/plasticizer. More formulation studies are warranted further to demonstrate the desired continuous drug release and maximum efficacy with Imatinib chemotherapy.
- 1 December 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (52B) , 144-150
Assessing the Molecular Interaction between Poly Lactic-co-glycolic Acid (PLGA) 50:50 and Poly Ethylene Glycol in Presence of Diethyl Phthalate Using in silico Study - A Novel Approach of Pre-Formulation Study
The efficacy of a drug relies on drug formulation and targeting. Imatinib is an anti-cancer drug identified to be effective in the treatment of cancers like myeloid leukemia and lymphoblastic leukemia, and gastrointestinal tumors. The prediction of mixing energy and identification of docking interactions and scores can help identify the most efficient drug carrier/plasticizer molecule that could exert maximum pharmaceutical efficiency. The results of a preliminary study explicitly showed the potent carrier molecule before conducting formulation studies. Hence, the present study was designed to screen the interaction energies between different combinations of Poly (lactic-co-glycolic acid) (PGLA) or Poly Ethylene Glycol (PEG) or diethyl phthalate with Imatinib using in silico computational methods. The study results suggested that the binding energy and the score obtained for docking interactions for Imatinib versus diethyl phthalate was better when compared to the other combinations. Therefore, Diethyl phthalate might be a signature candidate to act as Imatinib-carrier/plasticizer. More formulation studies are warranted further to demonstrate the desired continuous drug release and maximum efficacy with Imatinib chemotherapy.
- 23 January 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 34-42
Comparative Efficacies of Antimigraine Drugs Using Nitroglycerin Induced Migraine Rats Model
Aim: The migraine pathology is still not explained effectively. There is a common relationship between anxiety, depression, and migraine. So the aim of the study to illustrate effectively the behavioural and biomarker changes in the migraine condition. Methods: Nitroglycerin (NTG) induced migraine rats model was used the present study. Twenty-five male Wistar rats were randomly divided into five groups. Ergotamine, sumatriptan, and BIBN4096 were used as antimigraine drugs. The behavioural activity was measured by scratching head, body shaking, and social interaction task. ELISA detected biomarkers like interleukin 6 (IL-6), Substance P (SP) and 5-hydroxytryptamine (5-HT) in various rats brain regions such as cortex, brain stem, trigeminal ganglion. Results: A significant reduction in hyperalgesic response and behavioral changes like scratching head, body shaking and social interaction task. Biomarkers like 5-HT, SP and IL-6 were significantly reduced in the various brain regions such as prefrontal cortex, brain stem and trigeminal ganglia of the rats in the BIBN4096 treated groups. Conclusion: The present study showed a good antimigraine efficacy with a calcitonin gene-related peptide (CGRP) antagonistic agent BIBN4096 than ergotamine and sumatriptan but still lack of behavioural pattern, need to explore nonpharmacological intervention along with the drug treatment.
- 23 January 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- p. 34-42
Comparative Efficacies of Antimigraine Drugs Using Nitroglycerin Induced Migraine Rats Model
Aim: The migraine pathology is still not explained effectively. There is a common relationship between anxiety, depression, and migraine. So the aim of the study to illustrate effectively the behavioural and biomarker changes in the migraine condition. Methods: Nitroglycerin (NTG) induced migraine rats model was used the present study. Twenty-five male Wistar rats were randomly divided into five groups. Ergotamine, sumatriptan, and BIBN4096 were used as antimigraine drugs. The behavioural activity was measured by scratching head, body shaking, and social interaction task. ELISA detected biomarkers like interleukin 6 (IL-6), Substance P (SP) and 5-hydroxytryptamine (5-HT) in various rats brain regions such as cortex, brain stem, trigeminal ganglion. Results: A significant reduction in hyperalgesic response and behavioral changes like scratching head, body shaking and social interaction task. Biomarkers like 5-HT, SP and IL-6 were significantly reduced in the various brain regions such as prefrontal cortex, brain stem and trigeminal ganglia of the rats in the BIBN4096 treated groups. Conclusion: The present study showed a good antimigraine efficacy with a calcitonin gene-related peptide (CGRP) antagonistic agent BIBN4096 than ergotamine and sumatriptan but still lack of behavioural pattern, need to explore nonpharmacological intervention along with the drug treatment.
- 1 January 2021
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 14 (2) , 1115-1121
Cancer protective effect of Brassicca nigra and role of its chemical constituents
Brassica nigra, the black mustard, is an annual plant cultivated for its black or dark brown seeds, which are the members of Brassica genus (Family: Brassicaceae). It is an annual weedy plant which has immense edible as well as medicinal value. Brassica nigra consist of thirty-seven different species. Brassica vegetables contain low fat, high vitamin, mineral and fibre as well as various phytochemicals. It prevents oxidative stress, induce detoxification enzymes, stimulate the immune system, reduce cancer risk, and inhibit malign transformation and carcinogenic mutations in addition to reduce the proliferation of cancer cells. Globally cancer is a disease which severely effects the human population. There is a constant demand for new therapies to treat and prevent this life-threatening disease. Scientific and research interest is sketch its attention towards naturally-derived compounds as they are considered to have less toxic side effects compared to current treatments such as chemotherapy. The present study explores the anti-cancer activities of Brassica nigra plant comprising various chemical constituents and is necessitated by the current interest in plant products as a cheaper and far better alternative than the synthetic drugs available. This current review will bring concise information about the known mechanism of action and cancer activities of Brassica nigra.
- 1 January 2021
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 14 (2) , 1115-1121
Cancer protective effect of Brassicca nigra and role of its chemical constituents
Brassica nigra, the black mustard, is an annual plant cultivated for its black or dark brown seeds, which are the members of Brassica genus (Family: Brassicaceae). It is an annual weedy plant which has immense edible as well as medicinal value. Brassica nigra consist of thirty-seven different species. Brassica vegetables contain low fat, high vitamin, mineral and fibre as well as various phytochemicals. It prevents oxidative stress, induce detoxification enzymes, stimulate the immune system, reduce cancer risk, and inhibit malign transformation and carcinogenic mutations in addition to reduce the proliferation of cancer cells. Globally cancer is a disease which severely effects the human population. There is a constant demand for new therapies to treat and prevent this life-threatening disease. Scientific and research interest is sketch its attention towards naturally-derived compounds as they are considered to have less toxic side effects compared to current treatments such as chemotherapy. The present study explores the anti-cancer activities of Brassica nigra plant comprising various chemical constituents and is necessitated by the current interest in plant products as a cheaper and far better alternative than the synthetic drugs available. This current review will bring concise information about the known mechanism of action and cancer activities of Brassica nigra.
- 1 January 2020
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 13 (10) , 4895-4902
Central composite design based development and validation of an rp-hplc method for paclitaxel in bulk and pharmaceutical dosage form
Objective Development of an accurate, precise, robust, sensitive, economical and rapid isocratic reverse phase high performance liquid chromatography (RP-HPLC) technique complying quality by design (QbD) and validate according to ICH guidelines for the quantitative estimation of Paclitaxel in bulk and pharmaceutical dosage form. Method The simultaneous assessment of the Paclitaxel with Nilotanib as internal standard in bulk and pharmaceutical dosage forms with the help of chemometrics, multicriteria decision-making approach. The separation was achieved by utilizing Phenomenex Enable C18 column (Gemini, 15x4.6mm, 5μm particle size) and PDA-UV detection set at 230nm was developed and validation of Paclitaxel in pure form and pharmaceutical formulation, optimized by Derringer’s desirability functions. Chromatographic separation was consisted of a mixture of acetonitrile and KH2PO4 (70:30 %v/v, pH 4) adjusted with orthophosphoric acid and the flow rate of 0.8ml/min. Result Newly developed method resulted in eluting the drug at 3.928min, respectively. The regression coefficients (R2) were observed to be 0.999 for all models. The detection of limits (LOD) was about 9.498ng/ml and quantitation limits (LOQ) were about 31.66ng/ml. The relative standard deviation was observed to be 1.842%. Peak area ratio of the analyte and internal standard was used for the estimation of pharmaceutical formulations. Conclusion The method was validated by determining its precision, accuracy, and system stability. The results of the investigation demonstrated that the suggested RP-HPLC method is simple, rapid, precise and accurate, which is convenient for the routine determination of Paclitaxel in bulk and pharmaceutical dosage forms.
- 1 January 2020
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 13 (10) , 4895-4902
Central composite design based development and validation of an rp-hplc method for paclitaxel in bulk and pharmaceutical dosage form
Objective Development of an accurate, precise, robust, sensitive, economical and rapid isocratic reverse phase high performance liquid chromatography (RP-HPLC) technique complying quality by design (QbD) and validate according to ICH guidelines for the quantitative estimation of Paclitaxel in bulk and pharmaceutical dosage form. Method The simultaneous assessment of the Paclitaxel with Nilotanib as internal standard in bulk and pharmaceutical dosage forms with the help of chemometrics, multicriteria decision-making approach. The separation was achieved by utilizing Phenomenex Enable C18 column (Gemini, 15x4.6mm, 5μm particle size) and PDA-UV detection set at 230nm was developed and validation of Paclitaxel in pure form and pharmaceutical formulation, optimized by Derringer’s desirability functions. Chromatographic separation was consisted of a mixture of acetonitrile and KH2PO4 (70:30 %v/v, pH 4) adjusted with orthophosphoric acid and the flow rate of 0.8ml/min. Result Newly developed method resulted in eluting the drug at 3.928min, respectively. The regression coefficients (R2) were observed to be 0.999 for all models. The detection of limits (LOD) was about 9.498ng/ml and quantitation limits (LOQ) were about 31.66ng/ml. The relative standard deviation was observed to be 1.842%. Peak area ratio of the analyte and internal standard was used for the estimation of pharmaceutical formulations. Conclusion The method was validated by determining its precision, accuracy, and system stability. The results of the investigation demonstrated that the suggested RP-HPLC method is simple, rapid, precise and accurate, which is convenient for the routine determination of Paclitaxel in bulk and pharmaceutical dosage forms.
- Open Access
- 1 January 2020
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 32 (24) , 64-73
Assessing the Specificity of Paclitaxel towards the Marker Proteins of Breast Cancer Using In silico Molecular Docking Study
Breast cancer is highly prevalent next to lung cancer. Breast cancer occurs as a result of mutation in the genes like proto-oncogenes as well as tumor suppressor genes in a single clone of cells in the ductal and glandular regions of the breast. The drugs used to prevent breast cancer are Raloxifene hydrochloride and Tamoxifen citrate. The drugs used to treat breast cancer are Abemaciclib, Paclitaxel, Everolimus, Imatinib, Alpelisib, Anastrozole. Although several drug molecules had been developed, their specificity towards the potential breast cancer specific marker proteins such as activated threonine kinase 2/Protein kinase B (AKT2), cell division protein kinase 6 (CDK6), estrogen receptor (ER), human epidermal growth factor receptor type 2 (HER2), and poly ADP ribose polymerase1 (PARP1) need to be studied in silico. The present study was undertaken 1) to assess the specificity of paclitaxel towards the breast cancer specific marker proteins using molecular docking analysis and 2) to identify various physico-chemical properties of drug molecules including absorption, distribution, metabolism and excretion (ADME). The interaction between paclitaxel and the target proteins of breast cancer was analyzed using the Schrodinger Maestro Ver.2018.4. The results of the present study reveal that paclitaxel shows good binding interactions with the target proteins in the following order, ER > PARP1 > AKT2 >CDK6 > HER2. Among the five proteins, ER and PARP1 showed good binding interactions as compared to AKT2, CDK6 and HER2 proteins. The ADME properties of paclitaxel were predicted using QikProp module of Schrodinger Maestro version 2018.4. The present study warrant further studies which helps in the development of potent anticancer drug to treat breast cancer.
- 1 January 2020
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 32 (24) , 64-73
Open AccessAssessing the Specificity of Paclitaxel towards the Marker Proteins of Breast Cancer Using In silico Molecular Docking Study
Breast cancer is highly prevalent next to lung cancer. Breast cancer occurs as a result of mutation in the genes like proto-oncogenes as well as tumor suppressor genes in a single clone of cells in the ductal and glandular regions of the breast. The drugs used to prevent breast cancer are Raloxifene hydrochloride and Tamoxifen citrate. The drugs used to treat breast cancer are Abemaciclib, Paclitaxel, Everolimus, Imatinib, Alpelisib, Anastrozole. Although several drug molecules had been developed, their specificity towards the potential breast cancer specific marker proteins such as activated threonine kinase 2/Protein kinase B (AKT2), cell division protein kinase 6 (CDK6), estrogen receptor (ER), human epidermal growth factor receptor type 2 (HER2), and poly ADP ribose polymerase1 (PARP1) need to be studied in silico. The present study was undertaken 1) to assess the specificity of paclitaxel towards the breast cancer specific marker proteins using molecular docking analysis and 2) to identify various physico-chemical properties of drug molecules including absorption, distribution, metabolism and excretion (ADME). The interaction between paclitaxel and the target proteins of breast cancer was analyzed using the Schrodinger Maestro Ver.2018.4. The results of the present study reveal that paclitaxel shows good binding interactions with the target proteins in the following order, ER > PARP1 > AKT2 >CDK6 > HER2. Among the five proteins, ER and PARP1 showed good binding interactions as compared to AKT2, CDK6 and HER2 proteins. The ADME properties of paclitaxel were predicted using QikProp module of Schrodinger Maestro version 2018.4. The present study warrant further studies which helps in the development of potent anticancer drug to treat breast cancer.
- 1 October 2018
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 76, 232-244
Design, 3D QSAR modeling and docking of TGF-β type I inhibitors to target cancer
- 1 October 2018
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 76, 232-244
Design, 3D QSAR modeling and docking of TGF-β type I inhibitors to target cancer